A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

The group will discus and vote on whether to recommend Pfizer booster shots. The Food and Drug Administration's independent advisory committee will convene in open session Friday to review the latest ...

Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...

The Food and Drug Administration will likely authorize Pfizer's COVID-19 booster shot for adolescents aged 12 to 15 by next week, The Washington Post and The New York Times reported on Thursday. The ...

The Centers for Disease Control Director Dr. Rochelle Walensky signed off on booster shots for children ages 5 to 11 years old, paving the way for parents to get their children boosted as early as ...

During an appearance on CBS News Sunday, Pfizer CEO Albert Bourla said that Americans would need a fourth dose of a COVID-19 vaccine to fend off future variants of the virus. Speaking with anchor ...

NEW YORK, N.Y. — Pfizer and BioNTech announced Tuesday that they’ve made a request for the Food and Drug Administration (FDA) to authorize their COVID-19 booster shot for all adults. Specifically, the ...

Pfizer CEO Albert Bourla appeared on ABC's "This Week." Pfizer CEO Albert Bourla said on ABC's "This Week" Sunday it's possible to provide both COVID-19 booster shots as well as doses for people who ...

The U.S. Food and Drug Administration has approved emergency use authorization for a booster shot of the Pfizer-BioNTech vaccine to be given at least six months after completion of the second dose for ...

The Food and Drug Administration has issued approval for a booster shot of Pfizer's COVID-19 vaccine for children as young as 12. The Pfizer vaccine is the first booster shot to receive emergency ...